Merck plans to sell its allergy business unit to cut debt: Bloomberg
November 26, 2015 at 17:32 PM EST
(Reuters) - German drugs and chemicals maker Merck KGaA is planning to sell its allergy business, Allergopharma, Bloomberg reported, citing sources.